Door Drug

(redirected from Door-to-Drug Decision)
The time that elapses—ideally < 30 minutes—between when a patient with chest pain arrives at A&E/ER and there’s enough data to confirm an evolving acute MI, and the patient receives a thrombolytic—e.g., tPA, streptokinase